Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland
Læknablaðið November 3, 2023 Ragnar Olafsson, Karól Kvaran, Kristín Ketilsdóttir et al. 5 citations
A survey of 256 Icelandic mental health professionals—psychiatrists, general practitioners, and psychologists—found that most had little or no knowledge of psychedelic substances and expressed negative attitudes toward treatment with psilocybin mushrooms, though they supported ongoing scientific research. Around half of psychiatrists had received patient questions about psychedelic treatment, compared to 14.6% of general practitioners and 17.5% of psychologists. Respondents believed psilocybin treatment should be prescribed and provided by psychiatrists in specialized clinics or hospital psychiatric units. Scientific articles, colleague discussions, and media most influenced their attitudes. Most wanted further education on psychedelics, feeling the time has not yet come for their use in treating mental disorders in Iceland.